Trial Profile
Photodynamic therapy of actinic keratoses on the head and face with a novel, self-adhesive 5-aminolaevulinic acid patch.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 12 Mar 2009
Price :
$35
*
At a glance
- Drugs Aminolevulinic acid (Primary)
- Indications Actinic keratosis; Skin cancer
- Focus Therapeutic Use
- 12 Mar 2009 New trial record.
- 01 Feb 2009 Results published in Experimental Dermatology.